Fulcrum Therapeutics Inc. (FULC)
NASDAQ · Healthcare
Fulcrum Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 0 | 80.0M | 2.8M | 6.3M | 19.2M | 8.8M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -84.8M | -21.9M | -110.7M | -112.6M | -81.1M | -71.6M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -74.9M | -9.7M | -97.3M | -109.9M | -80.8M | -70.8M |
| Per Share Data | ||||||
| EPS (diluted) | $-1.18 | $-0.16 | $-1.59 | $-2.44 | $-2.29 | $-2.79 |
| Shares Outstanding (dil.) | 0M | 0M | 0M | 0M | 0M | 0M |
Fulcrum Therapeutics Inc. Income Statement — FAQ
Fulcrum Therapeutics Inc. (FULC) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FULC's income statement history?
The chart and table above show Fulcrum Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.